Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06542705 · ClinicalTrials.gov registry record · NA

Effect of Internal Brace on Outcomes Following ACL Reconstruction With BTB Autograft

A NA study of ACL Reconstruction, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT06542705 is a NA study of ACL Reconstruction that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 90 participants, below the 111-participant average among 4 other ACL Reconstruction trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06542705, a NA study of ACL Reconstruction, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess Anterior Cruciate Ligament (ACL) healing through analyzing clinical, radiographic, functional and patient-reported outcomes following ACL reconstruction with bone-tendon-bone autograft with and without internal bracing.

Conditions Studied

Interventions

  • DEVICE Arthrex Internal Brace
  • PROCEDURE ACL Reconstruction

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2025-03-17
Est. Completion 2029-03
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT06542705

The ClinicalTrials.gov registry entry for NCT06542705 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 111-participant average among 4 other ACL Reconstruction trials with a reported enrollment target (19% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with ACL Reconstruction appearing as the primary indexed condition, and to 2 interventions - of which Arthrex Internal Brace is the first listed.

NCT06542705 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06542705 about?

NCT06542705 is a clinical study titled "Effect of Internal Brace on Outcomes Following ACL Reconstruction With BTB Autograft". The purpose of this study is to assess Anterior Cruciate Ligament (ACL) healing through analyzing clinical, radiographic, functional and patient-reported outcomes following ACL reconstruction with bone-tendon-bone autograft with and without internal bracing.

What is the current status of trial NCT06542705?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2025-03-17. Estimated completion is 2029-03.

What conditions does trial NCT06542705 study?

This clinical trial studies the following conditions: ACL Reconstruction.

What interventions are being tested in trial NCT06542705?

The interventions under investigation include: Arthrex Internal Brace (DEVICE), ACL Reconstruction (PROCEDURE).

Who is sponsoring clinical trial NCT06542705?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06542705 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ACL Reconstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.